Randomized Phase 2 Dose Optimization Trial of Modakafusp Alfa in Relapsed/Refractory Multiple Myeloma (RRMM)
Journal Articles
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
publication date
has subject area
published in
Research
keywords
-
32 Biomedical and Clinical Sciences
-
3202 Clinical Sciences
-
3211 Oncology and Carcinogenesis
-
6.1 Pharmaceuticals
-
Clinical Research
-
Clinical Trials and Supportive Activities
-
Hematology
-
Infectious Diseases
Identity
Digital Object Identifier (DOI)
Additional Document Info
start page
end page
volume
issue